The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.00
Bid: 47.00
Ask: 49.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.255%)
Open: 48.00
High: 48.00
Low: 48.00
Prev. Close: 48.00
MIG3 Live PriceLast checked at -
Maven Income and Growth VCT 3 is an Investment Trust

To achieve long-term capital appreciation and generate income for Shareholders by investing in a diversified portfolio of securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

24 Apr 2023 12:51

RNS Number : 2549X
Maven Income and Growth VCT 3 PLC
24 April 2023
 

 

Maven Income and Growth VCT 3 PLC (the Company)

Result of Annual General Meeting

 

At the Annual General Meeting of the Company held at Kintyre House, 205 West George Street, on Monday 24 April 2023 at 12 noon, all of the Resolutions put to the Meeting were passed.

 

At the record date for the Annual General Meeting, being 20 April 2023, the total number of voting rights in the Company stood at and the total shares in issue were 113,495,613. The Company advises that for the Annual General Meeting, valid proxy appointments were made in respect of 6,491,022 shares and that the number of proxy votes lodged for each Resolution were as follows:

 

 

Resolutions

For

Discretion

Against

Withheld

Total

1

To receive the Directors' Report and audited Financial Statements

6,293,141

173,122

13,995

10,764

6,491,022

2

To approve the Directors' Remuneration Report

6,038,582

232,128

162,013

58,299

6,491,022

3

To approve the Directors' Remuneration Policy

5,788,540

247,253

268,580

186,649

6,491,022

4

To approve a final dividend payment

6,297,123

162,876

20,097

10,926

6,491,022

5

To re-elect Atul Devani as a Director

6,111,108

228,663

75,600

75,651

6,491,022

6

To re-elect David Allan as a Director

6,145,552

225,008

56,256

64,206

6,491,022

7

To re-elect Bill Nixon as a Director

6,125,828

238,656

68,740

57,798

6,491,022

8

To re-elect Keith Pickering as a Director

6,153,750

234,550

38,516

64,206

6,491,022

9

To appoint Johnston Carmichael LLP as Auditor

6,187,937

184,091

57,605

61,389

6,491,022

10

To authorise the Directors to fix the remuneration of the Auditor

6,256,536

179,224

42,525

12,737

6,491,022

11

To authorise the Directors to allot new shares

5,688,278

180,306

531,736

90,702

6,491,022

12

To authorise disapplication of pre-emption rights

5,437,776

163,876

844,717

44,653

6,491,022

13

To authorise the Company to purchase its own shares

5,589,688

163,876

732,634

4,824

6,491,022

14

To allow a General Meeting to be called on not less than 14 days' notice

5,970,210

186,185

298,509

36,118

6,491,022

 

A vote withheld is not a vote in law and any such votes have not been included in the votes for or against the respective Resolutions. The voting figures, along with a summary of questions submitted to the AGM and the Board's responses to them, will be available to view at: www.mavencp.com/migvct3.

 

A copy of the Resolutions passed at the 2023 AGM have been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism.

 

 

Issued on behalf of the Board

Maven Capital Partners UK LLP, Secretary

24 April 2023

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGNKQBQDBKDCQB
Date   Source Headline
1st Feb 20233:23 pmRNSUnaudited NAV and Proposed Final Dividend
12th Dec 20223:41 pmRNSDirectorate Change
12th Dec 20223:34 pmRNSStatement re Director's Other Quoted Directorships
9th Nov 20223:00 pmRNSResult of General Meeting
4th Nov 20222:35 pmRNSTransaction in Own Shares
31st Oct 20223:54 pmRNSTransaction in Own Shares
21st Oct 20222:45 pmRNSNet Asset Value(s)
7th Oct 20224:28 pmRNSPublication of a Prospectus
4th Oct 20223:30 pmRNSChange of Auditor
26th Aug 202210:04 amRNSIssue of Equity
22nd Aug 20229:33 amRNSStatement re Dividend Investment Scheme
29th Jul 202211:25 amRNSHalf-year Report
21st Jul 20224:38 pmRNSTransaction in Own Shares
13th Jul 202211:19 amRNSNet Asset Value and Interim Dividend
8th Jul 20223:28 pmRNSStatement re Joint Offers for Subscription
6th Jun 20222:15 pmRNSIssue of Equity
26th May 20225:02 pmRNSTransaction in Own Shares
26th Apr 202212:34 pmRNSIssue of Supplementary Prospectus
26th Apr 202210:51 amRNSIssue of Equity - Dividend Investment Scheme
21st Apr 20222:39 pmRNSStatement re Dividend Investment Scheme
6th Apr 20224:02 pmRNSNet Asset Value(s)
6th Apr 20221:45 pmRNSResult of AGM
5th Apr 20226:30 pmRNSIssue of Equity
23rd Mar 20225:10 pmRNSDirector/PDMR Shareholding
23rd Mar 20225:05 pmRNSIssue of Equity
21st Mar 20222:59 pmRNSPublication of Suppl.Prospcts
11th Mar 202211:35 amRNSIssue of Equity - Dividend Investment Scheme
10th Mar 202211:30 amRNSIssue of Equity
10th Mar 202211:20 amRNSStatement re Dividend Investment Scheme
7th Mar 20226:32 pmRNSAnnual Financial Report
22nd Feb 20222:27 pmRNSTransaction in Own Shares
18th Feb 20225:48 pmRNSIssue of Equity - Replacement Announcement
7th Feb 20221:53 pmRNSDirector/PDMR Shareholding
7th Feb 20221:52 pmRNSDirector/PDMR Shareholding
7th Feb 20221:50 pmRNSDirector/PDMR Shareholding
7th Feb 20221:48 pmRNSDirector/PDMR Shareholding
7th Feb 20221:47 pmRNSDirector/PDMR Shareholding
7th Feb 20221:46 pmRNSDirector/PDMR Shareholding
7th Feb 202210:50 amRNSIssue of Equity
4th Feb 20229:45 amRNSStatement re NAV and Final Dividend
31st Jan 20224:25 pmRNSStatement re Offer for Subscription
10th Jan 202212:43 pmRNSStatement re Offer for Subscription
5th Jan 202210:35 amRNSDividend Declaration
24th Nov 20214:45 pmRNSTransaction in Own Shares
29th Oct 202112:44 pmRNSNet Asset Value(s)
20th Oct 20214:46 pmRNSResult of General Meeting
20th Sep 20215:21 pmRNSPublication of a Prospectus
20th Sep 20214:57 pmRNSStatement re Change of Registrar
10th Sep 202112:34 pmRNSIssue of Equity
7th Sep 20213:08 pmRNSStatement re Dividend Investment Scheme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.